Bumper Offer - Urjas oil Just @ Rs. 1
Metoprolol + Olmesartan is an allopathic medicine The correct dosage of Metoprolol + Olmesartan depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Metoprolol + Olmesartan is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Metoprolol + Olmesartan is used -
Moderate
Mild
Common
Is the use of Metoprolol + Olmesartan safe for pregnant women?
Metoprolol + Olmesartan has many dangerous side effects in pregnant women. If you are pregnant, do not consume Metoprolol + Olmesartan without medical advice.
Is the use of Metoprolol + Olmesartan safe during breastfeeding?
Side effects of Metoprolol + Olmesartan on breastfeeding women are very mild.
What is the effect of Metoprolol + Olmesartan on the Kidneys?
Very few cases of side effects of Metoprolol + Olmesartan on kidney have been reported.
What is the effect of Metoprolol + Olmesartan on the Liver?
Metoprolol + Olmesartan may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Metoprolol + Olmesartan on the Heart?
Metoprolol + Olmesartan is rarely harmful for the heart.
Metoprolol + Olmesartan should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Metoprolol + Olmesartan unless your doctor advises you to do so -
Is this Metoprolol + Olmesartan habit forming or addictive?
No, there is no any evidence that Metoprolol + Olmesartan is addictive.
Interaction between Food and Metoprolol + Olmesartan
Metoprolol + Olmesartan may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Metoprolol + Olmesartan
Consuming Metoprolol + Olmesartan with alcohol can have many serious effects on your body.
It is recommended to avoid taking Metoprolol + Olmesartan with aspirin, because of the concurrent use of these two medicines which can reduce the antihypertensive activity of Metoprolol + Olmesartan. It also decreases the renal blood flow. Please consult your doctor before taking these two medicines at the same time.
Metoprolol + Olmesartan works by inhibiting the functioning of certain natural chemicals in the body like epinephrine, which in turn leads to the widening of the blood vessels. This abolishes heart rate, blood pressure, and strain on the heart.
Yes, Metoprolol + Olmesartan is safe to use, if taken in prescribed quantity and duration as advised by the doctor. However, few side effects are observed such as dizziness, depression, tiredness, bloating, and stomach pain. If you feel any of the above- mentioned side effects after taking medicine, please consult your doctor right away and follow his/her instructions.
Metoprolol + Olmesartan is a prescription drug so do not take it without consulting doctor. It can be harmful for the patient to take this medicine without a doctor's advice.
It is recommended to avoid taking Metoprolol + Olmesartan with ibuprofen because of the concurrent use of these two medicines can reduce the antihypertensive activity of Metoprolol + Olmesartan. It also decreases the renal blood flow. Please consult your doctor before taking these two medicines at the same time.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
